“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat

A trial of lenacapavir showed 100% protection against HIV infection. But cuts to foreign aid and criticism over its pricing put the brakes on a worldwide rollout. <b>Elna Schütz</b> asks if we’re now seeing the reprieve that advocates were hoping for

Authors

Publication Details

Journal
BMJ
Published
2025-11-27
DOI
https://doi.org/10.1136/bmj.r2452
Citations
1
Primary Topic
Science, Research, and Medicine
Type
article
Field-Weighted Citation Impact
1.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat

Ekkehard Schütz
1 citations
BMJ
Science, Research, and Medicine
1.70
article

“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat

Ekkehard Schütz
article en
1 citations

Abstract

A trial of lenacapavir showed 100% protection against HIV infection. But cuts to foreign aid and criticism over its pricing put the brakes on a worldwide rollout. <b>Elna Schütz</b> asks if we’re now seeing the reprieve that advocates were hoping for

BMJVol. 391
Openalex Percentile: Top 11%
Science, Research, and Medicine
1.70
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

“Miraculous” HIV drug to be rolled out after overcoming aid cuts threat — Ekkehard Schütz · BMJ (2025) | TGRS Research Map | TGRS